Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-16-012063
Filing Date
2016-08-08
Accepted
2016-08-08 06:22:24
Documents
44
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 528733
2 ex31-1.htm EX-31.1 10784
3 ex31-2.htm EX-31.2 10986
4 ex32-1.htm EX-32.1 8690
  Complete submission text file 0001493152-16-012063.txt   2932189

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE rttr-20160630.xml EX-101.INS 429230
6 XBRL SCHEMA FILE rttr-20160630.xsd EX-101.SCH 38172
7 XBRL CALCULATION FILE rttr-20160630_cal.xml EX-101.CAL 32518
8 XBRL DEFINITION FILE rttr-20160630_def.xml EX-101.DEF 139014
9 XBRL LABEL FILE rttr-20160630_lab.xml EX-101.LAB 282280
10 XBRL PRESENTATION FILE rttr-20160630_pre.xml EX-101.PRE 198043
Mailing Address 1880 CENTURY PARK EAST, SUITE 1000 LOS ANGELES CA 90067
Business Address 1880 CENTURY PARK EAST, SUITE 1000 LOS ANGELES CA 90067 310-203-1000
RITTER PHARMACEUTICALS INC (Filer) CIK: 0001460702 (see all company filings)

EIN.: 263474527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37428 | Film No.: 161812441
SIC: 2834 Pharmaceutical Preparations